Value Orientation

The Values of Investing in Dose-Managing and Dose-saving Technology

The need to reduce patients’ anxiety over dose is putting medical professionals under increased pressure to justify imaging procedures, and public discussions surrounding the question of dose are ongoing around the world. The need to justify further investments on an institutional side, into technology and specifically, into dose-managing technology, is pressing for healthcare decision makers as well.

Why should you invest in dose-managing and dose-saving technology?

At Siemens, it is our goal to provide you with a sound set of valuable arguments for investment of these sorts that focus on fulfilling clinical, operational and financial needs. With this approach we have the dual mandates in mind to improve patient safety and increase productivity, while ensuring the highest quality and cost-efficient patient care.


The Clinical Value of Right Dose

By investing into Siemens Right Dose technology you could foster:

  • Reduced potential for long-term damage in patients initiated by medical radiation
  • Less patient concerns about exposing themselves to too much radiation
  • Earlier detection in areas unthinkable before to help make prevention more reliable
  • Better diagnostic confidence to help more precise treatment and more precise treatment decisions

The Operational Value of Right Dose

By investing into Siemens Right Dose technology you could foster:

  • Awareness and transparency for patients and staff with quantifiable dose value reports
  • Limited exposure for users and better staff retention for your institution
  • Automated system settings and control with the aim of managing and reducing dose during scans that save time and money

The Financial Value of Right Dose

By investing into Siemens Right Dose technology you could foster:

  • Patient referrals as the attractiveness of your institution increases
  • Your competitive advantage when attracting top medical professionals with state-of-the-art technologies
  • Cost reduction from efficiency gains through reduced dose exposure for surgeons and operating staff
  • Revenue increase from higher reimbursement through high patient satisfaction scores